The FCTC at Twenty: Has the World's First Health Treaty Delivered?

When the WHO Framework Convention on Tobacco Control entered into force in 2005, it was hailed as a turning point in global public health—the first treaty negotiated under WHO auspices, a legally binding instrument that would coordinate the global response to the tobacco epidemic. The FCTC's core provisions—tax increases, smoke-free environments, advertising bans, health warnings, and cessation support—were evidence-based interventions that had already been shown to reduce smoking in high-income countries. The treaty's promise was that these interventions would be implemented globally, reducing the projected one billion tobacco deaths in the 21st century by accelerating the decline in smoking prevalence worldwide. Twenty years later, the FCTC has been ratified by 182 countries covering over 90% of the world's population. The question is whether it has worked—and whether its framework is adequate for the nicotine landscape of 2025 and beyond.

The FCTC's achievements are real and substantial. Smoking prevalence has declined globally from approximately 27% in 2000 to around 20% in 2022. The decline has been fastest in countries that implemented the FCTC's core provisions comprehensively—Australia, the UK, Brazil, Turkey, Uruguay—and slower in countries that ratified the treaty without implementing its provisions (the majority of low-income signatories). The treaty has provided a legal and political framework that empowered domestic tobacco control advocates, constrained industry interference, and normalized the idea that tobacco regulation is a legitimate function of government. Before the FCTC, the tobacco industry operated with near-total impunity in much of the world. After the FCTC, its room for maneuver has been significantly reduced. That is a genuine achievement.

The FCTC's limitations are equally real. The treaty's implementation has been profoundly uneven. High-income countries have adopted the FCTC's demand-reduction measures (taxation, smoke-free policies, advertising bans) while largely ignoring its supply-side measures (farmer transition, alternative livelihoods). Low-income countries—where the tobacco epidemic is increasingly concentrated, and where smoking prevalence remains high or rising—lack the resources and institutional capacity to implement the treaty's provisions. The FCTC secretariat has limited enforcement authority; the treaty operates through a Conference of the Parties (COP) that meets every two years and issues decisions that are binding in theory but unenforceable in practice. The result is a treaty that has widened the gap between countries that can implement tobacco control and countries that cannot—exactly the equity gap that the treaty was designed to close.

The FCTC's most consequential failure is its treatment of harm reduction. The treaty was negotiated in an era when 'tobacco control' meant 'cigarette control,' and the concept of safer nicotine products—vapes, pouches, snus, heated tobacco—was nascent or nonexistent. The treaty text is silent on harm reduction, but the COP has interpreted it as hostile. COP decisions have urged parties to prohibit or restrict e-cigarettes, have excluded harm reduction advocates and consumers from COP proceedings, and have treated the nicotine industry as a monolithic enemy to be excluded from all policy discussions. The WHO's position, as articulated in multiple reports and statements, is that the safety of e-cigarettes is 'inconclusive' and that their potential as cessation tools is 'unproven'—positions that are scientifically contested and that diverge sharply from the conclusions of public health agencies in the UK, New Zealand, and other countries with strong tobacco control records.

This hostility to harm reduction has created a schism within the global tobacco control community. Countries that have embraced harm reduction—the UK, New Zealand, Sweden, Norway, Canada—are increasingly at odds with the FCTC's orthodox interpretation, and their representatives have been marginalized within COP proceedings. Consumer advocacy groups, representing the people who use nicotine products, have been systematically excluded from the FCTC's policy processes despite the treaty's rhetorical commitment to participation and transparency. The FCTC, designed to be a framework for evidence-based policy, has become an instrument for enforcing a particular ideological interpretation of the evidence—one that is increasingly difficult to reconcile with the data on smoking prevalence trends in countries that have taken a different approach.

The FCTC's future depends on whether it can adapt. The treaty's twentieth anniversary is an opportunity to assess its record honestly—to celebrate the lives saved by the policies it catalyzed, and to acknowledge the lives that could have been saved if its approach to harm reduction had been different. Adaptation does not require abandoning the treaty's core provisions, which remain as relevant as ever. It requires opening the treaty's policy processes to new evidence, new voices, and new perspectives—including the perspectives of the billion-plus nicotine users whose lives are at stake. The FCTC was designed to serve the people harmed by tobacco. It will only remain fit for that purpose if it is willing to listen to them.

Shareable insight: The FCTC saved millions of lives by coordinating the global response to cigarette smoking. But its hostility to harm reduction—treating safer nicotine products as a threat rather than a tool—has prevented it from saving millions more. The treaty's next twenty years will be defined by whether it can adapt to the evidence it suppressed.